Product Images Dofetilide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Dofetilide NDC 69539-131 by Msn Laboratories Private Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication guide for Dofetilide Capsules, each containing 125mog (0.125mg) Dofetilide with 60 capsules per container. The usual dosage should be seen in the accompanying prescribing information. It should be stored at 15°C to 30°C (59°F to 86°F) and protected from moisture and humidity. The capsules should be dispensed in USP-child-resistant containers. The manufacturer is MSN Laboratories Private Limited in Telangana, India, and the distributor is MSN Pharmaceuticals Inc. in Piscataway, NJ. The guide should be dispensed to each patient by the pharmacist.*
This is a description for medication, specifically Dofetilide Capsules. Each capsule contains 250mg of the medication, and there are 60 capsules in each container. The recommended dosage can be found in the accompanying prescribing information. It is important to keep the medication stored at a temperature between 15 and 30 degrees Celsius and protected from moisture and humidity. The medication should only be dispensed in child-resistant containers. The manufacturer of this medication is VSN Laboratories Private Limited, and it should be dispensed with an accompanying medication guide. Issued in June 2019, this medication is only available with a prescription.*
The text describes the dosage and storage details for Dofetilide capsules containing 500 mcg of the medication. It also includes manufacturing and distribution details. The medication guide must be dispensed to patients by the pharmacist, and it is available by prescription only.*
This text provides instructions for administering dofetilide, a medication used to treat certain heart rhythm disorders. It outlines criteria that must be met before the medication can be used, including checking the patient’s QT or QTc values and creatinine clearance. The text provides dosing recommendations based on the patient’s Clcr value and gives instructions for post-dose adjustments. It warns of potential contraindications and advises to discontinue the medication if QT or QTc values increase significantly.*
This is a description of Dofetilide Capsules, which contains 125 mcg (0.125 mg) per dose. The role of the capsules is to treat an abnormal heart rhythm condition. It is recommended that they are taken orally upon prescription by a physician. The medicine is contained in 300 capsules with 250 being the maximum amount of doses per container. The instructions for storage are that the capsules should be kept at room temperature.*
This is a product description for Dofetilide Capsules, which contain 250 meg (0.25 mg) for intravenous administration. The capsule is suspended and contains 250 g, and is prescribed for serious medical conditions under proper medical supervision. The product conforms to USP standards.*
This appears to be a description of a medication called Dofetilide Capsules. The capsules are available in a dosage of 500mcg (0.5mg) and are intended for infusion. The text also provides some information about the manufacturer, distributor, and storage instructions.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.